Dec 27, 20232024 Prediction from Jeffrey Casberg, M.S., RPhCasberg is Vice President of Clinical Pharmacy at IPD Analytics LLC and a member of the Managed Healthcare Executive editorial advisory...
Nov 6, 2023Amgen Confirms US Aflibercept Filing As Regeneron Awaits Biocon Trial FateAmgen has thrown its hat in the ring to launch a US biosimilar to Regeneron’s Eylea eye-disease blockbuster.
Sep 21, 2023Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and MoreA wave of blockbuster generic drugs launches, new brand drugs that address unmet needs, and legislation that would bring transparency to...
Aug 29, 2023News ArticlesCMS Releases List of Drugs for Medicare Price NegotiationThe Centers for Medicare and Medicaid Services (CMS) has released the list of the first 10 drugs to be negotiated under the Inflation...
Aug 1, 2023News ArticlesUsing Technology to Transform Specialty Medication Access and AffordabilityWe need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior...